445 related articles for article (PubMed ID: 29885802)
1. Cross- immunity of a H9N2 live attenuated influenza vaccine against H5N2 highly pathogenic avian influenza virus in chickens.
Wang M; Wei Y; Pu J; Bing G; Sun Y; Sun H; Wei F; Liu J
Vet Microbiol; 2018 Jul; 220():57-66. PubMed ID: 29885802
[TBL] [Abstract][Full Text] [Related]
2. Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy.
Kim SM; Kim YI; Park SJ; Kim EH; Kwon HI; Si YJ; Lee IW; Song MS; Choi YK
J Virol; 2017 Mar; 91(6):. PubMed ID: 28077631
[TBL] [Abstract][Full Text] [Related]
3. Development of a dual-protective live attenuated vaccine against H5N1 and H9N2 avian influenza viruses by modifying the NS1 gene.
Choi EH; Song MS; Park SJ; Pascua PN; Baek YH; Kwon HI; Kim EH; Kim S; Jang HK; Poo H; Kim CJ; Choi YK
Arch Virol; 2015 Jul; 160(7):1729-40. PubMed ID: 25959557
[TBL] [Abstract][Full Text] [Related]
4. Heterosubtypic protection against avian influenza virus by live attenuated and chimeric norovirus P-particle-M2e vaccines in chickens.
Ghorbani A; Ngunjiri JM; Xia M; Elaish M; Jang H; Mahesh KC; Abundo MC; Jiang X; Lee CW
Vaccine; 2019 Feb; 37(10):1356-1364. PubMed ID: 30691981
[TBL] [Abstract][Full Text] [Related]
5. Vaccination with recombinant 4 × M2e.HSP70c fusion protein as a universal vaccine candidate enhances both humoral and cell-mediated immune responses and decreases viral shedding against experimental challenge of H9N2 influenza in chickens.
Dabaghian M; Latify AM; Tebianian M; Nili H; Ranjbar AR; Mirjalili A; Mohammadi M; Banihashemi R; Ebrahimi SM
Vet Microbiol; 2014 Nov; 174(1-2):116-26. PubMed ID: 25293397
[TBL] [Abstract][Full Text] [Related]
6. Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus.
Kapczynski DR; Esaki M; Dorsey KM; Jiang H; Jackwood M; Moraes M; Gardin Y
Vaccine; 2015 Feb; 33(9):1197-205. PubMed ID: 25613723
[TBL] [Abstract][Full Text] [Related]
7. Virus-like particles displaying H5, H7, H9 hemagglutinins and N1 neuraminidase elicit protective immunity to heterologous avian influenza viruses in chickens.
Pushko P; Tretyakova I; Hidajat R; Zsak A; Chrzastek K; Tumpey TM; Kapczynski DR
Virology; 2017 Jan; 501():176-182. PubMed ID: 27936463
[TBL] [Abstract][Full Text] [Related]
8. Generation of a reassortant avian influenza virus H5N2 vaccine strain capable of protecting chickens against infection with Egyptian H5N1 and H9N2 viruses.
Kandeil A; Moatasim Y; Gomaa MR; Shehata MM; El-Shesheny R; Barakat A; Webby RJ; Ali MA; Kayali G
Vaccine; 2016 Jan; 34(2):218-224. PubMed ID: 26620838
[TBL] [Abstract][Full Text] [Related]
9. Safety and immunogenicity of a live attenuated influenza H5 candidate vaccine strain A/17/turkey/Turkey/05/133 H5N2 and its priming effects for potential pre-pandemic use: a randomised, double-blind, placebo-controlled trial.
Pitisuttithum P; Boonnak K; Chamnanchanunt S; Puthavathana P; Luvira V; Lerdsamran H; Kaewkungwal J; Lawpoolsri S; Thanachartwet V; Silachamroon U; Masamae W; Schuetz A; Wirachwong P; Thirapakpoomanunt S; Rudenko L; Sparrow E; Friede M; Kieny MP
Lancet Infect Dis; 2017 Aug; 17(8):833-842. PubMed ID: 28533093
[TBL] [Abstract][Full Text] [Related]
10. Prior infection of chickens with H1N1 avian influenza virus elicits heterologous protection against highly pathogenic H5N2.
Nfon C; Berhane Y; Pasick J; Kobinger G; Kobasa D; Babiuk S
Vaccine; 2012 Nov; 30(50):7187-92. PubMed ID: 23084852
[TBL] [Abstract][Full Text] [Related]
11. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines.
Wang P; Zheng M; Lau SY; Chen P; Mok BW; Liu S; Liu H; Huang X; Cremin CJ; Song W; Chen Y; Wong YC; Huang H; To KK; Chen Z; Xia N; Yuen KY; Chen H
mBio; 2019 Sep; 10(5):. PubMed ID: 31530680
[TBL] [Abstract][Full Text] [Related]
12. A two dose immunization with an inactivated reassortant H5N2 virus protects chickens against lethal challenge with homologous 2.3.2.1 clade and heterologous 2.2 clade highly pathogenic avian influenza H5N1 viruses.
Bhat S; Sood R; Shukla S; Khandia R; Pateriya AK; Kumar N; Singh VK; Kalaiyarasu S; Kumar M; Bhatia S
Vet Microbiol; 2018 Apr; 217():149-157. PubMed ID: 29615248
[TBL] [Abstract][Full Text] [Related]
13. Live attenuated H5N1 vaccine with H9N2 internal genes protects chickens from infections by both highly pathogenic H5N1 and H9N2 influenza viruses.
Nang NT; Song BM; Kang YM; Kim HM; Kim HS; Seo SH
Influenza Other Respir Viruses; 2013 Mar; 7(2):120-31. PubMed ID: 22487301
[TBL] [Abstract][Full Text] [Related]
14. Generation and protective efficacy of a cold-adapted attenuated avian H9N2 influenza vaccine.
Wei Y; Qi L; Gao H; Sun H; Pu J; Sun Y; Liu J
Sci Rep; 2016 Jul; 6():30382. PubMed ID: 27457755
[TBL] [Abstract][Full Text] [Related]
15. Assessment of immune responses to H5N1 inactivated influenza vaccine among individuals previously primed with H5N2 live attenuated influenza vaccine.
Rudenko L; Naykhin A; Donina S; Korenkov D; Petukhova G; Isakova-Sivak I; Losev I; Stukova M; Erofeeva M; Nikiforova A; Power M; Flores J
Hum Vaccin Immunother; 2015; 11(12):2839-48. PubMed ID: 26697973
[TBL] [Abstract][Full Text] [Related]
16. Homologous and heterologous antigenic matched vaccines containing different H5 hemagglutinins provide variable protection of chickens from the 2014 U.S. H5N8 and H5N2 clade 2.3.4.4 highly pathogenic avian influenza viruses.
Kapczynski DR; Pantin-Jackwood MJ; Spackman E; Chrzastek K; Suarez DL; Swayne DE
Vaccine; 2017 Nov; 35(46):6345-6353. PubMed ID: 28456525
[TBL] [Abstract][Full Text] [Related]
17. [Stimulation of homo- and heterologic T-cell immunological memory in volunteers inoculated with live influenza A (H5N2) reassortant vaccine].
Naĭkhin AN; Chirkova TV; Petukhova GD; Koren'kov DA; Donina SA; Rudenko LG
Vopr Virusol; 2012; 57(1):38-42. PubMed ID: 22624472
[TBL] [Abstract][Full Text] [Related]
18. Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.
Desheva JA; Lu XH; Rekstin AR; Rudenko LG; Swayne DE; Cox NJ; Katz JM; Klimov AI
Vaccine; 2006 Nov; 24(47-48):6859-66. PubMed ID: 17050041
[TBL] [Abstract][Full Text] [Related]
19. Improved hatchability and efficient protection after in ovo vaccination with live-attenuated H7N2 and H9N2 avian influenza viruses.
Cai Y; Song H; Ye J; Shao H; Padmanabhan R; Sutton TC; Perez DR
Virol J; 2011 Jan; 8():31. PubMed ID: 21255403
[TBL] [Abstract][Full Text] [Related]
20. Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus.
Römer-Oberdörfer A; Veits J; Helferich D; Mettenleiter TC
Vaccine; 2008 May; 26(19):2307-13. PubMed ID: 18395947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
